(919) 224-8800 Contact Our Team

What You'll Learn:  

  • What are biomarkers and how can they be used in novel ways?
  • How to use biomarkers to determine diagnoses, diagnostic accuracy, treatment plans and tracking responses
  • How to leverage PK/PD quantitative data to guide study design and development decisions
  • How to develop a targeted vs. reactive patient recruiting plan
  • Considerations for adaptive approach to trial design

Who Should Listen:  

  • Regulatory/Scientific Affairs
  • CMO
  • Medical Directors
  • R&D
  • Senior level clinical operations staff


Lee Schacter, PhD, MD, FACP
Executive Medical Director, Oncology, Clinipace Worldwide

Martha Bonino
Director, Strategic Accounts, Clinipace Worldwide

Afshin Safavi, Ph.D.
Founder & Chief Scientific Officer, BioAgilytix

Free Webcast:

Oncology Drug Development Using Molecular Pathology

Download the webcast now!